![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1352117
¼¼°èÀÇ ±âµµ °ü¸® ±â±â ½ÃÀå(2023-2030³â)Global Airway Management Devices Market - 2023-2030 |
±âµµ °ü¸®´Â ´Ü¼øÇÑ Áú½ÄºÎÅÍ º¹ÀâÇÑ ±âµµ Æó¼â±îÁö ´Ù¾çÇÑ »óȲ¿¡¼ ÇÊ¿äÇÒ ¼ö ÀÖ½À´Ï´Ù. ±âµµ Æó¼â´Â Çô³ª À̹°ÁúÀÌ ±âµµ¸¦ ¸·¾Æ¼ ¹ß»ýÇÏ´Â °æ¿ì°¡ °¡Àå ÈçÇÕ´Ï´Ù. ¶ÇÇÑ ±âµµ ¼Õ»ó, Ç÷¾×À̳ª ºÐºñ¹°(Ÿ¾×, Á¡¾× µî)ÀÇ Áõ°¡, ±âµµÀÇ ¿°ÁõÀ¸·Î ÀÎÇØ ¹ß»ýÇÒ ¼öµµ ÀÖ½À´Ï´Ù.
¶ÇÇÑ, È£Èí±â ÁúȯÀÇ À¯º´·ü Áõ°¡, ¼ö¼ú °Ç¼ö Áõ°¡¿¡ µû¸¥ ¸¶ÃëÁ¦ »ç¿ë·® Áõ°¡, ÀÇ·áºñ Áõ°¡, ÀÇ·á ÀÎÇÁ¶ó ¹ßÀü, ÀÇ·á ¼ºñ½º È®´ë¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µî ´Ù¾çÇÑ ¿äÀο¡ ÀÇÇØ È£Èí±â °ü¸® ÀåÄ¡ ½ÃÀåÀÌ °ßÀεǰí ÀÖÀ¸¸ç, ÀÌ ¸ðµç °ÍÀÌ È£Èí±â °ü¸® ÀåÄ¡ ½ÃÀå¿¡ ÀÌÀÍÀ» °¡Á®´ÙÁÖ°í ÀÖ½À´Ï´Ù. ÀÌÀÍÀ» °¡Á®¿À°í ÀÖ½À´Ï´Ù.
´ÙÀ̳ª¹Í½º
È£Èí±â ÁúȯÀÇ À¯º´·ü Áõ°¡
È£Èí±â ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀÇ Áß¿äÇÑ ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. È£Èí±â ÁúȯÀÌ Áõ°¡ÇÔ¿¡ µû¶ó È£Èí±â °ü¸® ÀåÄ¡ÀÇ »ç¿ëÀº Á¾Á¾ ºü¸£°Ô »ç¿ëµÇ°í ÀÖÀ¸¸ç, ÀÌ´Â ½ÇÁ¦·Î ½ÃÀå ¼ºÀåÀ» Áõ°¡½Ãŵ´Ï´Ù. ¿¹¸¦ µé¾î, Centers for Disease Control and Prevention(Centers for Disease Control and Prevention)¿¡ µû¸£¸é, COPD´Â ¾à 2¾ï ¸íÀÌ ¾Î°í ÀÖÀ¸¸ç ¸Å³â 320 ¸¸ ¸íÀÌ »ç¸ÁÇÏ¿© ¼¼°è 3 À§ÀÇ »ç¸Á ¿øÀÎÀ¸·Î ÃßÁ¤µË´Ï´Ù.
õ½ÄÀº °¡Àå ÈçÇÑ ºñ°¨¿°¼º Áúȯ Áß Çϳª·Î Àü ¼¼°è 2¾ï 6,200¸¸ ¸íÀÌ ¾Î°í ÀÖÀ¸¸ç, 2022³â¿¡´Â ¾à 2,200¸¸ ¸íÀÌ »õ·Î Æó¾Ï¿¡ °É·Á 180¸¸ ¸íÀÌ »ç¸ÁÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, Æó¾ÏÀº Àü ¼¼°è ¾Ï »ç¸ÁÀÚ 4¸í Áß 1¸íÀÌ Æó¾ÏÀ¸·Î »ç¸ÁÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Çϱ⵵ °¨¿° ¶Ç´Â Æó·ÅÀº ÁÖ·Î ÁßÀú¼Òµæ ±¹°¡(LMICs)¿¡¼ ¸Å³â 2,400¸¸ ¸í ÀÌ»óÀÌ »ç¸ÁÇÏ´Â ÁÖ¿ä »ç¸Á ¿øÀÎÀ̸ç, COVID-19·Î ÀÎÇØ Àü ¼¼°èÀûÀ¸·Î Æó·ÅÀ¸·Î ÀÎÇÑ »ç¸ÁÀÚ ¼ö°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
±âµµ °ü¸®¿¡ ÀÖ¾î ±â¼úÀûÀ¸·Î Áøº¸µÈ ÀåºñÀÇ °³¹ßÀÌ Áõ°¡
±âµµ °ü¸®¿¡ ÀÖ¾î ±â¼úÀûÀ¸·Î Áøº¸µÈ ÀåÄ¡ÀÇ °³¹ßÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ±âµµ °ü¸® ±â±â ½ÃÀåÀÌ ¿¹Ãø ±â°£ µ¿¾È ¼ºÀåÇÒ ¼ö ÀÖ´Â ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù.
¿¹¸¦ µé¾î, 2022³â 1¿ù, ICU Medical Inc.´Â Smiths Group PLC·ÎºÎÅÍ Smiths Medical Àμö¸¦ ¿Ï·áÇÏ¿© ±âµµ °ü¸® ±â±â, ¹ÙÀÌÅ» Äɾî Á¦Ç°, ¿Ü·¡ ¼ö¾× ÀåÄ¡ µî Á¦Ç° Æ÷Æ®Æú¸®¿À¸¦ Àü ¼¼°èÀûÀ¸·Î È®ÀåÇÏ¿© ȯÀÚ Ä¡·á °æÇèÀ» °³¼±Çϰí, Àü¹ÝÀûÀÎ Ä¡·á °á°ú¸¦ °³¼±Çϰí ÀÖ½À´Ï´Ù.
ȯ±Þ Á¤Ã¥ÀÇ ºÎÀç
ÀǷẸÇèÁ¦µµ°¡ ¿¾ÇÇϱ⠶§¹®¿¡ °³¹ßµµ»ó±¹¿¡¼´Â °í°¡ÀÇ ±âµµ°ü¸®ÀåÄ¡ÀÇ µµÀÔ·üÀÌ ³·½À´Ï´Ù. ¼¼°èÀºÇà±×·ì¿¡ µû¸£¸é 1ÀÎ´ç ¿¬°£ Æò±Õ ÀÇ·áºñ´Â 80´Þ·¯·Î ±¹¹ÎµéÀº ¸¸¼ºÁúȯ°ú COVID-19 À¯Çິ¿¡ Ãë¾àÇÕ´Ï´Ù.
Àü ±¹¹Î ÀǷẸÇèÀ» À§ÇÑ ÀçÁ¤ ºÎÁ·Àº 2030³â±îÁö ÃÖºó±¹ 54°³±¹¿¡¼ 1,760¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ºñµð¿À Èĵΰæ°ú °°Àº ÀÇ·á±â±â ¹× °í±Þ ¼ö¼ú ¹æ¹ýÀÇ Ã¤ÅÃÀÌ Á¦ÇѵǾî ÀÖ¾î ±âµµ °ü¸® ±â±âÀÇ ½ÃÀå Á¡À¯À²ÀÌ Á¦ÇѵǾî ÀÖ½À´Ï´Ù.
Airway management may be required for individuals in a variety of circumstances, ranging from simple choking to complicated airway obstruction. Airway obstruction most commonly occurs as a result of the tongue or foreign bodies blocking the airway. It can also be the result of injury to the airway, increased presence of blood and secretions (e.g., saliva and mucus), or inflammation of the airway.
Futhermore, the airway management devices market is driven by various factors like rising prevalence of respiratory diseases, and as the number of surgeries increases, so does the use of anaesthesia, the increase in healthcare spending, advancements in healthcare infrastructure, and a high demand for expanded care delivery all benefit the airway management device market.
Increase prevalence of respiratory disease is one the key driver that helps the market to grow during forecast period. Since rise in respiratory diseases the use of airway managmenet devices are often used rapdily which indeed will increase the market growth. For instance, according to the Centres for Disease Control and Prevention COPD affects an estimated 200 million people, with 3.2 million dying each year, making it the third-leading cause of mortality globally.
Asthma is one of the most common noncommunicable illnesses, impacting 262 million people worldwide.With almost 2.2 million new instances of lung cancer expected in 2022 and 1.80 million fatalities, lung cancer accounts for one in every four cancer deaths worldwide. Lower respiratory tract infection or pneumonia is a prominent cause of death, accounting for more than 2.4 million fatalities each year, primarily in low and middle-income countries (LMICs). COVID-19 has significantly increased pneumonia fatalities worldwide.
Rise in developing technologically advanced devices in airway management is one of the key driver that helps the airway management devices market to grow during the forecast period.
For instance, in January 2022, ICU Medical Inc., completed the acquisition of Smiths Medical from Smiths Group PLC, to increase the product portfolio globally in devices for airway management, vital care products, ambulatory infusion devices, and others to enhance the patient treatment experience and improve overall outcomes.
Due to poor healthcare insurance programmes, developing nations have low adoption rates for pricey airway management devices. According to the World Bank Group, the average yearly healthcare expenditure is $80 per person, making the population more prone to chronic sickness and COVID-19 epidemics.
The financial shortfall for universal health care is anticipated to reach $176 billion by 2030 among the 54 poorest countries. The limited adoption of medical equipment such as video laryngoscopes and sophisticated surgical methods restricts the market share of airway management devices.
The global airway management devices is segmented based on type, age, end user and region.
The laryngoscopes from type segment with around 42.5% is expected to dominate during the forecast period. Laryngoscopy is a visual examination using a throat scope to view the larynx, which contains vocal cords. It helps diagnose ear or throat pain, airway blockages, throat narrowing, and swallowing difficulties.
For instance, in April 2022 OMNIVISION, a leading global developer of semiconductor solutions, including advanced digital imaging, analog and touch & display technology, launched new laryngoscope reference designs that include a range of OMNIVISION products that help improve patient care by providing crisp, clear images for single-use video laryngoscopes. Visualization makes insertion of the endotracheal tube easier and faster and avoids failures in difficult airways, significantly reducing the chances of complications and even death.
North America is estimated to hold about 38.4 % of the total market share throughout the forecast period, owing to the rising R&D and introduction of new technologies in devices of airway management by key players to help aid in patient treatment is likely to drive the North America market growth. Moreover, increasing collaborations among manufacturing players and rising approvals of new airway devices with extensive presence across the region also drive the this region in future.
For instance, on June 21, 2023 Teleflex Incorporated a leading global provider of medical technologies, announced a partnership with Shenzhen Insighters Medical Technology Co., Ltd. As the exclusive U.S. distributor of the Insighters Video Laryngoscope system, which is designed to inspect the upper glottic airway and facilitate endotracheal intubation.
The major global players in the airway management devices market include: Medtronic , Boston Scientific Corporation , Olympus Corporation, ICU Medical, Inc, ConvaTec Group Plc, KARL STORZ, Teleflex Incorporated , Ambu A/S , Verathon Inc, SourceMark and among others.
The COVID-19 epidemic has increased the number of patients admitted to emergency departments and intensive care units. Patients suffering from severe infections typically have respiratory failure or low oxygen saturation, necessitating the use of positive air pressure devices such as ventilators. As a result, demand for airway control devices, particularly single-use devices, is increasing.
As non-invasive methods carry the potential of virus particle aerosolization, the number of patients requiring intubation via invasive airway management procedures has grown. Healthcare practitioners that provide airway management treatment to COVID-19 patients and other patients in healthcare institutions are putting themselves at danger, which has boosted the need for single-use devices.
The Russia-Ukraine conflict is estimated to have a moderate impact on the global airway management devices, owing to the low prevalence and absence of key market players in this region. However, the impact of the import and export of devices is expected to have little influence over the global airway management devices growth over the forecast period.
The global airway management devices market report would provide approximately 53 tables, 54 figures and 195 pages.
Australia
LIST NOT EXHAUSTIVE